Amphera BV   Report issue

For profit Phase 3
Founded: Hertogenbosch Netherlands (2012)

Organization Overview

First Clinical Trial
2018
NCT03610360
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Amphera BV